Autoimmune Ênsights

immune Health Lab + Consultation Bundles

Autoimmune disorders are a growing concern. We proudly partner with Cyrex labs to focus on the fast growing health issues of autoimmune disorders now affecting tens of millions of people in the United States alone. Our advanced specialty panels are designed to evaluate your immune reactions using Cyrex’s proprietary, advanced technology.

For all specialty and supplemental services, we require all of our patients to be under the direct care of a local or Primary Care Physician (PCP) who manages day-to-day routine and urgent care.

What gets measured, gets managed.

Measure and track all the way to your health goals with Whoop.

Join our Whoop team and use your weekly and monthly biometric reporting to inform your health coaching sessions, track your progress, and reach your goals faster.

Join Whoop >

Essential Barrier Screen + Lymphocyte Mapping

GAM assesses overall production of Immunoglobulin G, Immunoglobulin A and Immunoglobulin M in the body—an
important measurement of general immunity. Total immunoglobulins testing can be a strong indicator of a disease or condition. This panel can shed light on the potential cause of unexpected negative results on Cyrex testing by identifying whether insufficient antibody production may have contributed to those results. Additionally, acquired immunodeficiency may be reversible when the contributing condition is identified and addressed.. Learn more

Total Serum IgG/IgA/IgM

Array 2 measures intestinal permeability to large molecules, which inflame the immune system. Clinically utilized with patients with present multiple symptom complaints (including chronic fatigue syndrome), complain of food sensitivity and intolerance, and/or suffer from abnormal immune cell count and function (including autoimmune diseases). Learn more

Intestinal Antigenic Permeability Screen

Blood Brain Barrier Permeability Screen

Array 20 assists in the assessment of increased risk of neurodegenerative disorders, including but not limited to multiple sclerosis, Lou Gehrig's disease, senile dementia, Alzheimer's disease, Parkinson's disease, epilepsy and stroke. Helps in the early investigation of contact sports-related traumatic brain injury (TBI), and evaluates the breach of the Blood-Brain barrier caused by stress, trauma or environmental triggers, even in the absence of apparent concussion or brain injury. Clinically utilized for patients with history of playing contact sports during which repeated head trauma occurs, engage in activity that involves force or shock to the head and/or body, have intestinal permeability with abnormal elevation in LPS and/or Occludin/Zonulin antibodies, exhibit changes in cognitive function. Learn more

Irritable Bowel/SIBO Screen

Array 22 provides a more accurate test for Irritable Bowels and SIBO by assessing IgG, IgA and IgM antibodies to bacterial cytotoxins and cytoskeletal proteins. With Array 22 one can identify a trigger of irritable bowels and the specific intestinal barrier damage they cause. It improves upon the standard breath test for SIBO by eliminating the need for exhaustive dietary restriction and collection protocols for patients, while providing better specificity and sensitivity through serum antibody testing. Clinically utilized for patients who have irritable bowels, exhibit symptoms of malabsorption, including weight loss, anemia or fatty stools, have associated conditions such as fatigue, reflux, skin disorders, obesity or food intolerances. Learn more

Cyrex Comprehensive Lymphocyte Immunophenotyping

The Lymphocyte Map™ is an innovative test which establishes a new standard in screening the immune system. It measures the integrity of the immune system at the cellular level to help identify a patient's immune status and immunotype(s), based on 35 determinations. Recommended for those with immune system dysfunction, immunodeficiency, hyper-inflammation, autoimmunity, allergies, hypersensitivities induced by environmental trigger(s). Learn more

Multiple Autoimmune Reactivity Screen

Mucosal Immune Reactivity Screen

The mucosal immune system is the body’s first line of defense against antigen invasion. The Mucosal Immune Reactivity panel evaluates mechanisms of compromised immune
tolerance and possible outcomes of compromised
mucosal tolerance, such as: intestinal barrier
dysfunction, food and chemical immune reactivity,
and autoimmunity. Learn more

Multiple Autoimmune Reactivity Screen

Measures predictive autoantibodies, some of which can appear up to 10 years before clinical symptoms. Efficiently and economically assesses possible tissue damage to multiple
organs of the body. Clinically considered with patients already diagnosed with an autoimmune disorder, as they commonly develop additional autoimmune conditions, as well as patients with chronic increased intestinal permeability, which is the gateway for environmentally-induced
autoimmune disorders. Learn more

Multiple Autoimmune Reactivity Screen

Wheat/Gluten Proteome Reactivity and Autoimmunity

A comprehensive wheat/gluten reactivity test, which assists in the identification of wheat reactivity, non-celiac gluten sensitivity, Celiac disease, food opioid reactivity, intestinal barrier damage, and wheat-related autoimmunity. Clinically useful in identifying possible Celiac disease, non-celiac gluten sensitivity, dermatitis herpetiformis, gluten ataxia or other wheat/gluten-related disorder and assessing autoimmune reactivity associated with wheat proteins and peptides. Learn more

Gluten-Associated Cross-Reactive Foods and Food Sensitivity

A comprehensive wheat/gluten reactivity test, which assists in the identification of wheat reactivity, non-celiac gluten sensitivity, Celiac disease, food opioid reactivity, intestinal barrier damage, and wheat-related autoimmunity. Clinically useful in identifying possible Celiac disease, non-celiac gluten sensitivity, dermatitis herpetiformis, gluten ataxia or other wheat/gluten-related disorder and assessing autoimmune reactivity associated with wheat proteins and peptides. Learn more

Food Immune Reactivity Screen

This unique, revolutionary panel measures reactivity to 180 food antigens in the cooked, raw, modified or processed form on the same panel. Array 10 assists in early detection of dietary-related triggers of autoimmune reactivity and monitors the effectiveness of customized dietary protocols. Clinically utilized for patients seeking a life-long health and wellness strategy, present with unexplained symptoms (whether gastrointestinal, neurological, dermatological or behavioral in nature). and/or are suspected of having increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders. Learn more

Chemical Immune Reactivity Screen

Array 11 identifies the loss of immune intolerance associated with toxic chemical exposure, which may lead to autoimmune reactivity. It assists in setting guidelines for the avoidance of specific chemicals to reduce the risk of igniting the autoimmune process, and monitoring the effectiveness of the clinical management of protocols. Clinically utilized for patients with increased chemical sensitivities/intolerance.
Have loss of immune tolerance and/or abnormal immune function. Learn More

Pathogen-Associated Immune Reactivity Screen

Array 12 - (PAIRS), assesses immune response to 29 viral, bacterial, fungal, parasitic and stealth organism antigens that may be latent in the body. Understanding which dormant pathogens are triggers of cross-reactivity, immune reactivity, and potential autoimmune reactivity is crucial for better addressing patient needs. Clinically utilized for patients who present with chronic conditions such as gastrointestinal distress, fatigue, body aches or unexplained and general inflammation, including neuroinflammation, patients who may have been exposed to bacteria, viruses, parasites, molds and spirochetes associated with multiple autoimmunities, and/or patients who have not fully responded to clinical interventions, such as detoxification and dietary modifications. Learn More

Specialty Testing:
Cognitive Function Brain Health

Identify and address the early signs of Alzheimer's Disease and other neurological disorders.

Alzheimer's LINX™ makes it easier to identify the route of pathogenesis leading to cognitive decline and devise strategies to stop it. By addressing Blood-Brain Barrier breakdown, identifying and removing triggers and enhancing neuronal regeneration, one might be able
to win the war on cognitive decline. Learn more

Cyrex Alzheimer’s Linx

Sample Collection for Testing

Oral Fluid

Blood